The benefits of this stockIt recently occured to me that this stock is priced near its COVID lows. 2022 was also a complete disaster, and the stock is still way less than half its pre-pandemic era valuation.
So yeah when you talk about a dirt cheap stock this is it.
But let me ask a very serious question: what is management doing to increase this company's revenues? They basically sold off some legacy assets and replaced them with not enough money making assets and then had to audacity to include some b/s about lower mortality rates.
Who here seriously believes that people are just suddenly dying less often now?